Jaundice in a patient treated with Anakinra in a context of Covid-19

Infect Dis Now. 2021 Mar;51(2):217-218. doi: 10.1016/j.medmal.2020.09.011. Epub 2020 Sep 30.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged, 80 and over
  • COVID-19 Drug Treatment*
  • Female
  • Humans
  • Hyperbilirubinemia / chemically induced*
  • Interleukin 1 Receptor Antagonist Protein / adverse effects*
  • Jaundice / chemically induced*
  • SARS-CoV-2*

Substances

  • Interleukin 1 Receptor Antagonist Protein